CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system

[1]  D. Weigent.  Universes in Delicate Balance: Chemokines and the Nervous System , 2003 .

[2]  M. Humbert,et al.  CX3C Chemokine Fractalkine in Pulmonary Arterial Hypertension , 2002 .

[3]  G. Tarozzo,et al.  Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia‐reperfusion brain injury in the rat , 2002, The European journal of neuroscience.

[4]  D. Huszar,et al.  Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury , 2002, Journal of Neuroimmunology.

[5]  V. Perry,et al.  Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS , 2002, Glia.

[6]  Richard J. Miller,et al.  Regulation of calcium currents by chemokines and their receptors , 2002, Journal of Neuroimmunology.

[7]  I. Charo,et al.  Tumor Necrosis Factor- (cid:1) -converting Enzyme Mediates the Inducible Cleavage of Fractalkine* , 2022 .

[8]  C. Blobel,et al.  Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). , 2001, The Journal of biological chemistry.

[9]  A. Foussat,et al.  Deregulation of the expression of the fractalkine/fractalkine receptor complex in HIV-1-infected patients. , 2001, Blood.

[10]  D. Salant,et al.  Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection , 2001 .

[11]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[12]  S. Lira,et al.  Generation and Analysis of Mice Lacking the Chemokine Fractalkine , 2001, Molecular and Cellular Biology.

[13]  P. Allavena,et al.  Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. , 2001, The Journal of clinical investigation.

[14]  S. Gordon,et al.  The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo. , 2001, The American journal of pathology.

[15]  L. Santambrogio,et al.  Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression , 2000, Journal of Neuroimmunology.

[16]  K. Moores,et al.  Fractalkine Cleavage from Neuronal Membranes Represents an Acute Event in the Inflammatory Response to Excitotoxic Brain Damage , 2000, The Journal of Neuroscience.

[17]  A. Sher,et al.  Analysis of Fractalkine Receptor CX3CR1 Function by Targeted Deletion and Green Fluorescent Protein Reporter Gene Insertion , 2000, Molecular and Cellular Biology.

[18]  A. Yamauchi,et al.  Fractalkine-Mediated Endothelial Cell Injury by NK Cells1 , 2000, The Journal of Immunology.

[19]  J. Harrison,et al.  Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasis , 2000, Journal of Neuroimmunology.

[20]  P. Green,et al.  The role of fractalkine in the recruitment of monocytes to the endothelium. , 2000, European journal of pharmacology.

[21]  Sandra A. Kinnear,et al.  Neuronal Fractalkine Expression in HIV-1 Encephalitis: Roles for Macrophage Recruitment and Neuroprotection in the Central Nervous System1 , 2000, The Journal of Immunology.

[22]  A. Foussat,et al.  Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human , 2000, European journal of immunology.

[23]  L. Feng,et al.  Inflammatory agents regulate in vivo expression of fractalkine in endothelial cells of the rat heart , 1999, Journal of leukocyte biology.

[24]  R. Maki,et al.  Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. , 1999, Journal of immunology.

[25]  R. Miller,et al.  Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Schall,et al.  Neuronal expression of fractalkine in the presence and absence of inflammation , 1998, FEBS letters.

[27]  D. Patel,et al.  Fractalkine and CX3CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic Flow , 1998, The Journal of experimental medicine.

[28]  W. Streit,et al.  Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  P. Lewczuk,et al.  Intercellular adhesion molecule-1 in cerebrospinal fluid—the evaluation of blood-derived and brain-derived fractions in neurological diseases , 1998, Journal of Neuroimmunology.

[30]  A. Akaike,et al.  Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? , 1998, FEBS letters.

[31]  T. Schall,et al.  Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.

[32]  J. Gutiérrez-Ramos,et al.  Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation , 1997, Nature.

[33]  Wei Wang,et al.  A new class of membrane-bound chemokine with a CX3C motif , 1997, Nature.

[34]  J. Harrison.  Constitutive Roles for SDF-1/CXCR4 and Fractalkine/CX3CR1 in the CNS , 2002 .

[35]  D. Cornblath,et al.  Assessment of current diagnostic criteria for Guillain‐Barré syndrome , 1990, Annals of neurology.